Dr. Bailes provided a comprehensive overview of current legislative and regulatory activities affecting clinical oncologists. Topics to be addressed include the status of legislation on Medicare payment for drugs, physician treatment planning, and imaging. Regulatory issues that will be reviewed include coverage of off-label drug uses, clinical trials policy, and pay-for-performance programs.

Download the presentation.

Support for this meeting was provided by AMGEN, biogenIDEC, Cephalon Oncology, Genentech BioOncology, Genomic Health, International Oncology Network/Oncology Supply, McKesson Specialty Oncology Services, MGI Pharma, Millennium, Novartis Oncology, Oncology Pharmaceutical Services, Ortho Biotech, OSI Pharmaceuticals, Pfizer Oncology, Pharmion, Roche Oncology, and Sanofi Aventis Oncology.